CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies Collaboration expands CRISPR Therapeutics’ efforts in immuno-oncology ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 22, 2017 (GLOBE...
Oxford Immunotec Global PLC Announces Pricing of Underwritten Public Offering of Ordinary Shares OXFORD, United Kingdom and MARLBOROUGH, Mass., August 15, 2017 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company...
Binary Fountain and Kyruus Announce Partnership to Enhance Patient Acquisition and Engagement for Health Systems by Kyruus, on Aug 15, 2017 8:55:42 AM The seamless integration of Binary Star Ratings and Kyruus ProviderMatch for Consumers will enable health systems to...
Deciphera Pharmaceuticals Announces Pricing of Initial Public Offering WALTHAM, Mass., Sept. 27, 2017 (GLOBE NEWSWIRE) — Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug...
Karus Therapeutics Announces First Cancer Patients Dosed with KA2507, a Small Molecule HDAC6-Selective Inhibitor, in a Phase I Clinical Trial Oxfordshire, UK, 18th September 2017 – Karus Therapeutics Ltd (‘Karus’), a leader in the design and development of innovative...
Recent Comments